(Q46577413)

23 December 2017

title

Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats (English)

1 reference

23 December 2017

0 references

Ahmad Agil

1

1 reference

23 December 2017

Isaac Rosado

2

1 reference

23 December 2017

Rosario Ruiz

3

1 reference

23 December 2017

Adriana Figueroa

4

1 reference

23 December 2017

Nourahouda Zen

5

1 reference

23 December 2017

Gumersindo Fernández-Vázquez

6

1 reference

23 December 2017

publication date

25 August 2011

1 reference

23 December 2017

Journal of Pineal Research

published in

1 reference

23 December 2017

volume

52

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

203-210

1 reference

23 December 2017

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Childhood overweight, obesity, and the metabolic syndrome in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Adipokines: the missing link between insulin resistance and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Leptin and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Role of adipokines in complications related to obesity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Adiponectin as a biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Adipocytokines and the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Current views on type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Endoplasmic reticulum stress in beta-cells and development of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Beta-cell deterioration during diabetes: what's in the gun?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Role of melatonin in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Melatonin: action as antioxidant and potential applications in human disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Melatonin as a natural ally against oxidative stress: a physicochemical examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

New evidence for a role of melatonin in glucose regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Variants in MTNR1B influence fasting glucose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Experimental rat models to study the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Effect of sitagliptin plus metformin on β-cell function, islet integrity and islet gene expression in Zucker diabetic fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Clinical uses of melatonin: evaluation of human trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

In vivo and in situ action of melatonin on insulin secretion and some metabolic implications in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Depression of glucose levels and partial restoration of pancreatic beta-cell damage by melatonin in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Adipocyte differentiation is inhibited by melatonin through the regulation of C/EBPbeta transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Pinealectomy and melatonin administration in rats: their effects on plasma leptin levels and relationship with zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Effects of melatonin administration on plasma leptin concentration and adipose tissue leptin secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Effects of short-term feed deprivation and melatonin implants on circadian patterns of leptin in the horse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Effect of a high-fat diet on 24-hour pattern of circulating adipocytokines in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00928.X

10.1111/J.1600-079X.2011.00928.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

21883445

1 reference

23 December 2017